Design of modified reference phase modulation based boost chopper fed fifteen level stepped DC link hybrid converter.

A new fifteen-level stepped DC to AC hybrid converter is proposed for Solar Photovoltaic (SPV) applications. A boost chopper circuit is designed and interfaced with the fifteen-level hybrid converters specific to Electric Vehicles' Brushless DC Motor (BLDC) drive systems. In chopper units, the output of solar panels is regulated and stepped up to obtain the nominal output voltage. In the stepped DC-link hybrid converter configuration, fifteen-level DC-link voltage is achieved by the series-operated DC-link modules with reduced electrical energy compression. From the comprehensive structure, it is anecdotal that the proposed topology has achieved minimum switching and power loss. Elimination of end passive components highlights the merits of the proposed hybrid systems. The reduction of controlled power semiconductor switches and gate-firing circuits has made the system more reliable than other hybrid converters. From the extensive analysis, the experimental setup has reported that 7% reduction in harmonics and a 54% reduction in controlled power switches than the existing fifteen-level converter topologies. Mitigation of power quality issues in the voltage profile of a fifteen-level multilevel hybrid converter is achieved through the implementation of dsPIC digital-controller-based gate triggering circuits.

An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis.

Malignant cancer angiogenesis has historically attracted enormous scientific attention. Although angiogenesis is requisite for a child's development and conducive to tissue homeostasis, it is deleterious when cancer lurks. Today, anti-angiogenic biomolecular receptor tyrosine kinase inhibitors (RTKIs) to target angiogenesis have been prolific in treating various carcinomas. Angiogenesis is a pivotal component in malignant transformation, oncogenesis, and metastasis that can be activated by a multiplicity of factors (e.g., VEGF (Vascular endothelial growth factor), (FGF) Fibroblast growth factor, (PDGF) Platelet-derived growth factor and others). The advent of RTKIs, which primarily target members of the VEGFR (VEGF Receptor) family of angiogenic receptors has greatly ameliorated the outlook for some cancer forms, including hepatocellular carcinoma, malignant tumors, and gastrointestinal carcinoma. Cancer therapeutics have evolved steadily with active metabolites and strong multi-targeted RTK inhibitors such as E7080, CHIR-258, SU 5402, etc. This research intends to determine the efficacious anti-angiogenesis inhibitors and rank them by using the Preference Ranking Organization Method for Enrichment Evaluation (PROMETHEE- II) decision-making algorithm. The PROMETHEE-II approach assesses the influence of growth factors (GFs) in relation to the anti-angiogenesis inhibitors. Due to their capacity to cope with the frequently present vagueness while ranking alternatives, fuzzy models constitute the most suitable tools for producing results for analyzing qualitative information. This research's quantitative methodology focuses on ranking the inhibitors according to their significance concerning criteria. The evaluation findings indicate the most efficacious and idle alternative for inhibiting angiogenesis in cancer.